Chronic Myeloproliferative Disorders Terminated Phase 1 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00800150Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to TreatmentTreatment